Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 5,662.00
+12.00 (0.21%)
At close: Dec 19, 2025
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 93.76 billion as of December 19, 2025. Its market cap has increased by 6.89% in one year.
Market Cap
93.76B
Enterprise Value
90.96B
Revenue
12.84B
Ranking
n/a
PE Ratio
30.56
Stock Price
5,662.00
Market Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 93.76B, an increase of 862.09%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 93.76B | 7.84% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | 113.12B | 56.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.19T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.01T |
| Zydus Lifesciences | 925.33B |
| Mankind Pharma | 896.65B |
| Aurobindo Pharma | 711.54B |
| Fortis Healthcare | 672.59B |